Lucintel Forecasts the Global Acute Ocular Pain Market is expected to grow with a CAGR of 9.3% from 2024 to 2030
Lucintel Forecasts the Global Acute Ocular Pain Market is expected to grow with a CAGR of 9.3% from 2024 to 2030
Blog Article
According to a market report by Lucintel, the future of the global acute ocular pain market looks promising with opportunities in the hospital, homecare, and ophthalmic clinic markets. The global acute ocular pain market is expected to grow with a CAGR of 9.3% from 2024 to 2030. The major drivers for this market are rising elderly population leading to an increased occurrence of ocular conditions, increased research and development activities, and growing need for advanced diagnostic tools and techniques to improve eye screening procedures.
A more than 150 – page report is developed to understand Trends, opportunity and forecast in acute ocular pain market to 2030 by drug (topical NSAIDs, topical cycloplegic agents, oral analgesics, corticosteroids, and immunomodulators), medical condition (corneal abrasion, glaucoma, conjunctivitis, iritis, and others), route of administration (topical, periocular, intraocular, oral, and others), end use (hospitals, homecare, ophthalmic clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
In this market, corneal abrasion, glaucoma, conjunctivitis, and iritis are the major segments of acute ocular pain market by medical condition. Lucintel forecasts that corneal abrasion is expected to witness the highest growth over the forecast period.
Within this market, hospital is expected to witness the highest growth due to growing elderly population worldwide and the increasing quantity of hospitals.
Download sample by clicking on acute ocular pain market
APAC is expected to witness highest growth over the forecast period due to rapidly growing population.
Alcon Vision, Bausch + Lomb, Sun Pharmaceutical Industries, AbbVie, Ocular Therapeutix, KALA BIO, Formosa Pharmaceuticals, Vyluma, Sylentis, and Aldeyra Therapeutics are the major suppliers in the acute ocular pain market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1 972.636.5056
Explore Our Latest Publications
Programmable Ethernet Switch Market
Smart Wiring Devices Market
Sports Electronics Market
Transient Voltage Suppressor Diode Market
Tunnel Field Effect Transistor Market